In a manic week full of previously unthinkable market moves, Wall Street on Friday ended with one reminiscent of what things were like before the COVID-19 pandemic upended everything.
The S&P 500 glided to a gain of 1.4 percent, with Apple Inc, Microsoft Corp and other technology stocks leading the way, as they did so many times before the US economy shut down in the hopes of slowing the spread of the novel coronavirus.
The bond market was quiet, while crude prices climbed again.
The gains offered a soothing coda for a wild week, which began with Monday’s astonishing plummet for oil and carried through Thursday’s sudden disappearance of a morning stock rally, as markets pinballed from fear to hope and back again.
“The market sort of feels like Dorothy coming to the crossroads and has yet to meet the scarecrow to tell her which way to go,” Center for Financial Research and Analysis chief investment strategist Sam Stovall said.
The S&P 500 still lost 1.3 percent for the week as worries about the economic damage dealt by the pandemic outweighed hopes that businesses could soon reopen. That snapped the first two-week winning streak for the S&P 500 since it began selling off in February.
Reports piled higher through the week showing that the pandemic is bludgeoning the US economy even more than economists had feared. Roughly one in six US workers has filed for unemployment benefits over the past five weeks.
The damage is so severe that a heavily divided US Congress has reached bipartisan agreement on massive support for the economy.
US President Donald Trump on Friday signed a bill to provide nearly US$500 billion more, including loans for small businesses and aid for hospitals.
The big question for markets is when the US economy can reopen, Harvest Volatility Management head of trading and research Mike Zigmont said.
Businesses can get by for a few months on government help, but if the shutdown drags on longer, they could be permanently damaged, he said.
Many investors have essentially agreed to swallow horrific corporate profits and economic data in upcoming months, and they are turning their focus to who can survive and eventually grow their profits.
Next week is to be one of the busiest of this earnings season, with more than 150 companies in the S&P 500 reporting how much they made in the first three months of this year.
Many companies have been pulling their profit forecasts entirely for this year given all the uncertainty, and Wall Street is slashing its own estimates.
“I don’t really think that’s added to the concern of investors, because they assume that companies will be doing a lot of writing down in this bad year so that 2021 could look even better,” Stovall said.
The S&P 500 on Friday added 38.94 points to 2,836.74.
The Dow Jones Industrial Average on Friday rose 260.01 points, or 1.1 percent, to 23,775.27, falling 1.9 percent from a close of 24,242.49 on April 17.
The NASDAQ Composite on Friday added 139.77 points, or 1.7 percent, to 8,634.52, edging down 0.2 percent from 8,650.14 a week earlier.
The Russell 2000 index of small company stocks on Friday gained 18.99 points, or 1.6 percent, to 1,233.05, a 0.3 percent increase from 1,229.10 on April 17.
Gains for big tech stocks led the way. Tech makes up an outsized portion of the S&P 500 following years of market dominance, and because changes in market value dictate the index’s moves, the performance of the biggest stocks can have a disproportionate effect.
Stocks have been generally rallying since late last month on promises for massive aid from Congress and the US Federal Reserve, along with more recent hopes that parts of the US economy might be close to reopening.
In Georgia, some businesses on Friday began welcoming back customers after Georgia Governor Brian Kemp eased a month-long shutdown.
However, many professional investors have been skeptical of the market’s recent rally, saying that there is still too much uncertainty about how long the recession would last and that attempts to reopen the US economy could trigger more waves of infections if they are premature.
In a demonstration of how hungry the market is for a vaccine or treatment for COVID-19, the S&P 500 on Thursday erased a rally of more than 1 percent in a span of seconds following a discouraging report about a potential drug treatment.
The Financial Times reported that a Chinese study of the Gilead Sciences Inc’s experimental antiviral drug remdesivir found no positive effect, citing data published accidentally by the WHO.
However, Gilead said that the data represented “inappropriate characterizations” of the study.
Through all the volatility, many investors saving for retirement have been holding steady. They have been calling in for advice much more often, but the majority of savers with 401(k) accounts at Fidelity Investments Inc did not pull back on their contributions in this quarter.
The S&P 500 is down 16.2 percent from its record in February, although it has more than halved its loss since late last month.
The yield on the 10-year US Treasury note slipped from 0.61 percent late on Thursday to 0.60 percent.
Yields tend to fall when investors are downgrading their expectations for the economy and inflation.
Additional reporting by staff writer
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Singapore-based ride-hailing and delivery giant Grab Holdings Ltd has applied for regulatory approval to acquire the Taiwan operations of Germany-based Delivery Hero SE's Foodpanda in a deal valued at about US$600 million. Grab submitted the filing to the Fair Trade Commission on Friday last week, with the transaction subject to regulatory review and approval, the company said in a statement yesterday. Its independent governance structure would help foster a healthy and competitive market in Taiwan if the deal is approved, Grab said. Grab, which is listed on the NASDAQ, said in the filing that US-based Uber Technologies Inc holds about 13 percent of
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday received government approval to deploy its advanced 3-nanometer (3nm) process at its second fab currently under construction in Japan, the Ministry of Economic Affairs said in a news release. The ministry green-lit the plan for the facility in Kumamoto, which is scheduled to start installing equipment and come online in 2028 with a monthly production capacity of 15,000 12-inch wafers, the ministry said. The Department of Investment Review in June 2024 authorized a US$5.26 billion investment for the facility, slated to manufacture 6- to 12nm chips, significantly less advanced than 3nm process. At a meeting with
Taiwan’s food delivery market could undergo a major shift if Singapore-based Grab Holdings Ltd completes its planned acquisition of Delivery Hero SE’s Foodpanda business in Taiwan, industry experts said. Grab on Monday last week announced it would acquire Foodpanda’s Taiwan operations for US$600 million. The deal is expected to be finalized in the second half of this year, with Grab aiming to complete user migration to its platform by the first half of next year. A duopoly between Uber Eats and Foodpanda dominates Taiwan’s delivery market, a structure that has remained intact since the Fair Trade Commission (FTC) blocked Uber Technologies Inc’s
RSS